EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrating Radiotherapy and Systemic Therapy in Hepatocellular Carcinoma: From Biological Rationale to Clinical Evidence

Narine Vartanian, Sophia Bishop, Joseph Tang, Kyle C. Cuneo, Daniel T. Chang, Theodore S. Lawrence, Ameer L. Elaimy

Current Oncology · 03.11.2026 · 33 (11) · 672

DOI: 10.3390/curroncol33110672 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Oncology, online erschienen am 03.11.2026. Verfasst von Narine Vartanian und 6 weiteren Autor:innen. Die Arbeit nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The therapeutic landscape of hepatocellular carcinoma (HCC) has evolved with advances in systemic therapy and radiotherapy. Immune-checkpoint inhibitors, anti-angiogenic agents, stereotactic body radiotherapy (SBRT), and yttrium-90 transarterial radioembolization (TARE) have expanded treatment options across multiple stages of disease. Radiotherapy may complement systemic therapy through biological interactions involving tumor vasculature, hypoxia, and the immune microenvironment. These observations have generated growing interest in combined-modality therapy, although optimal approaches continue to be defined. In this review, we summarize the biological rationale and clinical evidence for integrating SBRT or TARE with targeted and immunotherapy-based regimens. We also highlight ongoing trials and emerging strategies for biologically informed therapy sensitization targeting tumor and immune-cell biology.

Zitieren

APA

Vartanian, N., Bishop, S., Tang, J., Cuneo, K. C., Chang, D. T., Lawrence, T. S., & Elaimy, A. L. (2026). Integrating Radiotherapy and Systemic Therapy in Hepatocellular Carcinoma: From Biological Rationale to Clinical Evidence. Current Oncology, 33(11), 672. https://doi.org/10.3390/curroncol33110672

Vancouver

Vartanian N, Bishop S, Tang J, Cuneo KC, Chang DT, Lawrence TS, et al. Integrating Radiotherapy and Systemic Therapy in Hepatocellular Carcinoma: From Biological Rationale to Clinical Evidence. Current Oncology. 2026;33(11):672. doi:10.3390/curroncol33110672

BibTeX
@article{Vartanian2026,
  author = {Vartanian, Narine and Bishop, Sophia and Tang, Joseph and Cuneo, Kyle C. and Chang, Daniel T. and Lawrence, Theodore S. and Elaimy, Ameer L.},
  title = {Integrating Radiotherapy and Systemic Therapy in Hepatocellular Carcinoma: From Biological Rationale to Clinical Evidence},
  journal = {Current Oncology},
  year = {2026},
  volume = {33},
  number = {11},
  pages = {672},
  doi = {10.3390/curroncol33110672}
}
Kostenlos starten →